FOCAL STIMULATION OF THE MOSSY FIBERS RELEASES ENDOGENOUS DYNORPHINS THAT BIND KAPPA-1-OPIOID RECEPTORS IN GUINEA-PIG HIPPOCAMPUS

被引:68
作者
WAGNER, JJ
EVANS, CJ
CHAVKIN, C
机构
[1] UNIV WASHINGTON,SCH MED,DEPT PHARMACOL,SJ-30,SEATTLE,WA 98195
[2] UNIV CALIF LOS ANGELES,DEPT PSYCHIAT,LOS ANGELES,CA 90024
关键词
HIPPOCAMPUS; DYNORPHINS; OPIOID RELEASE; KAPPA-1; RECEPTORS; GUINEA PIG;
D O I
10.1111/j.1471-4159.1991.tb02132.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Physiological release of endogenous opioids in guinea pig hippocampal slices was detected in an in vitro competition binding assay using [H-3]U69,593, a kappa-1-selective radioligand. Veratridine-induced opioid release caused a decrease in [H-3]U69,593 binding that was blocked by either tetrodotoxin addition or the removal of calcium from the incubation buffer. Focal electrical stimulation of opioid peptide-containing afferent pathways resulted in a decrease in [H-3]U69,593 binding, whereas stimulation of a major afferent lacking endogenous opioid immunoreactivity had no effect. The addition of 6-cyano-7-nitroquinoxaline-2,3-dione blocked the reduction in [H-3]U69,593 binding caused by perforant path stimulation, but not the reduction caused by mossy fiber stimulation, suggesting that the primary source of endogenous kappa ligands was likely to be the dentate granule cells. Antisera against dynorphin A(1-8) or dynorphin B peptides inhibited the effects of mossy fiber stimulation in the [H-3]U69,593 displacement assay. Antisera against other prodynorphin- and proenkephalin-derived opioid peptides had no effect. As shown by receptor autoradiography, the distribution of kappa-1 binding sites was limited to the molecular layer of the dentate gyrus and the presubiculum region of temporal hippocampal slices. These results indicate that prodynorphin-derived opioids released under physiological conditions from the mossy fibers act at kappa-1 receptors in the guinea pig dentate gyrus.
引用
收藏
页码:333 / 343
页数:11
相关论文
共 43 条
[1]   ENDOGENOUS OPIOIDS - BIOLOGY AND FUNCTION [J].
AKIL, H ;
WATSON, SJ ;
YOUNG, E ;
LEWIS, ME ;
KHACHATURIAN, H ;
WALKER, JM .
ANNUAL REVIEW OF NEUROSCIENCE, 1984, 7 :223-255
[2]  
[Anonymous], 1967, STEREOTAXIC ATLAS FO
[3]  
Bayer S.A, 1985, RAT NERVOUS SYSTEM, V1, P335
[4]   BIDENTATE PEPTIDES - HIGHLY POTENT NEW INHIBITORS OF ENKEPHALIN DEGRADING ENZYMES [J].
BOUBOUTOU, R ;
WAKSMAN, G ;
DEVIN, J ;
FOURNIEZALUSKI, MC ;
ROQUES, BP .
LIFE SCIENCES, 1984, 35 (09) :1023-1030
[5]  
CAUDLE R, 1991, IN PRESS J PHARM EXP
[6]  
CAUDLE RM, 1990, J PHARMACOL EXP THER, V252, P1361
[7]   DYNORPHIN IS A SPECIFIC ENDOGENOUS LIGAND OF THE KAPPA-OPIOID RECEPTOR [J].
CHAVKIN, C ;
JAMES, IF ;
GOLDSTEIN, A .
SCIENCE, 1982, 215 (4531) :413-415
[8]  
Chavkin C, 1988, NIDA Res Monogr, V82, P94
[9]   SELECTIVE INACTIVATION OF OPIOID RECEPTORS IN RAT HIPPOCAMPUS DEMONSTRATES THAT DYNORPHIN-A AND DYNORPHIN-B MAY ACT ON MU-RECEPTORS IN THE CA1 REGION [J].
CHAVKIN, C ;
HENRIKSEN, SJ ;
SIGGINS, GR ;
BLOOM, FE .
BRAIN RESEARCH, 1985, 331 (02) :366-370
[10]   SPECIFIC RECEPTOR FOR THE OPIOID PEPTIDE DYNORPHIN - STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
CHAVKIN, C ;
GOLDSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (10) :6543-6547